Page 36 - FIMM_Brochure_2022
P. 36

Research
                                                     Director
                                                     Katja Kivinen
                                                     appointed
                                                     head of          Covid-19 HGI project

                                                     FIMM
                                                     Technology
                                 Professor              Centre        Caroline Heckman
                                 Mark Daly                                 appointed
                                 nominated
                                 Director                             Research Director,
                                 of FIMM                              Precision Medicine
                                                       iCAN:
                                                     Academy
                                                     of Finland
                                                     Flagship         ERC Starting Grant
 meets                           Research Director   (2019–26)         to Andrea Ganna          FIMM meets
a event                             Janna Saarela                                            Pharma webinars
ting Grant                       appointed Director
g Tang                           of NCMM                                                          Intervene
                                                     FIMM-EMBL Group FInnGen study             H2020 project
                                                     Leaders Andrea   enters phase 2
                                                     Ganna, Esa Pitkänen with 12 pharma
                                 AoF Centre of       & Hanna Ollila   partners
                                 Excellence in                                                                          Vision: Foundational science, tech-
                                 Complex Diseases                                                                      nology and data developed in FIMM’s
                                                                                                                       first 15 years are positively impacting
              FinnGen Study                          VEIL.AI spinout                            FIMM is main
                begins with                              company                               Finnish provider          the healthcare of Finnish citizens
                                                                                                of SARS-CoV-2           and delivering molecular medicine
            7 pharma partners                                                                sequencing for THL
                                                                                                                                  solutions globally.

016                              2018                                 2020                                       2022

            2017                                     2019                                    2021                                  2030

             FIMM joins HiLIFE                        New SAB                                                    EMBL Delegation
                    SAB Visit                        nominated                                                      Visit & Mini-
                                                                                                                    symposium
                  FIMM hosts                          SAB Visit                                                        SAB Visit
            the 8th Nordic EMBL                                                                                     FIMM hosts
            Partnership Meeting                                                        250+                          the EU-LIFE
                                                                                                                       Strategy
                                                                                                                       Meeting
   31   32   33   34   35   36   37   38